Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Pathology is the study of the nature of disease, including its causes, development and consequences. An integral part of Boston Children's commitment to providing your child with the best possible care is determining why your child needs medical care. Our Pathology Department is dedicated to answering that question.
Available 24 hours a day, 365 days a year, the Department of Pathology at Boston Children's Hospital is the largest service of its kind in the world. Our team studies blood, tissue, body fluids and other samples to diagnose and treat children's diseases.
Our pathology researchers seek to uncover innovative new approaches to the prevention, diagnosis and treatment of children's diseases while sharing our results with the research community at large.
Some of the many research projects our team is involved with are:
Our researchers, including Hanno Steen, PhD, discovered a protein detectable in urine that might serve as a biomarker for children with acute appendicitis, potentially preventing thousands of unnecessary surgeries each year.
Using advanced technologies, a multidisciplinary research team consisting of geneticists, pathologists and surgeons at Boston Children's Hospital has identified the genetic basis for CLOVES syndrome, a rare congenital malformation and overgrowth disorder.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”